HCPCS Code J9042: Brentuximab Vedotin, 1 mg

Learn how HCPCS Code J9042 is billed for brentuximab vedotin (Adcetris) injection, 1 mg, including coding details for Medicare and oncology claims.

Use Code

Frequently asked questions

HCPCS code J9042 represents the injection of brentuximab vedotin, 1 mg, a chemotherapy drug used for treating certain types of lymphoma.

Brentuximab vedotin is used to treat Hodgkin lymphoma, systemic anaplastic large cell lymphoma, and other CD30-expressing lymphomas. It targets cancer cells expressing the CD30 protein.

ADCetris (brentuximab vedotin) is an antibody-drug conjugate that combines targeted immunotherapy with a chemotherapy agent, functioning as a targeted chemotherapy.

Yes, vedotin refers to the chemotherapy component monomethyl auristatin E (MMAE) linked to the antibody in brentuximab vedotin, which disrupts microtubules in cancer cells to inhibit their growth.